Deferiprone oral solution ( DrugBank: Deferiprone )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
120	遺伝性ジストニア	2

120. 遺伝性ジストニア

臨床試験数 : 26 / 薬物数 : 19 - (DrugBank : 3) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 2

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02174848 (ClinicalTrials.gov)	June 2014	5/6/2014	Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration	Long-term Safety and Efficacy Study of Deferiprone in Patients With Pantothenate Kinase-Associated N ...	Pantothenate Kinase-Associated Neurodegeneration	Drug: Deferiprone oral solution	ApoPharma	NULL	Completed	5 Years	N/A	All	68	Phase 3	United States;Germany;Italy;United Kingdom
2	NCT01741532 (ClinicalTrials.gov)	December 13, 2012	3/12/2012	Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegene ...	A Randomized, Double-blind, Placebo-controlled Trial of Deferiprone in Patients With Pantothenate Ki ...	Pantothenate Kinase-Associated Neurodegeneration	Drug: Deferiprone oral solution;Drug: Placebo	ApoPharma	Food and Drug Administration (FDA)	Completed	4 Years	N/A	All	89	Phase 3	United States;Germany;Italy;United Kingdom;Poland

First Previous1Next Last